|
IT1195304B
(it)
|
1981-12-22 |
1988-10-12 |
Anic Spa |
Metodo per la preparazione di gem-diammino derivati n-monoacilati
|
|
US4631211A
(en)
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
|
US4698327A
(en)
|
1985-04-25 |
1987-10-06 |
Eli Lilly And Company |
Novel glycopeptide derivatives
|
|
IT1190389B
(it)
|
1985-09-19 |
1988-02-16 |
Eniricerche Spa |
Esapeptidi ad attivita' ipotensiva
|
|
US5169933A
(en)
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
|
IT1227907B
(it)
|
1988-12-23 |
1991-05-14 |
Eniricerche S P A Milano Sclav |
Procedimento per la sintesi di peptidi retro-inversi e nuovi intermediin tale procedimento
|
|
US6316003B1
(en)
|
1989-12-21 |
2001-11-13 |
Whitehead Institute For Biomedical Research |
Tat-derived transport polypeptides
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
US5670617A
(en)
|
1989-12-21 |
1997-09-23 |
Biogen Inc |
Nucleic acid conjugates of tat-derived transport polypeptides
|
|
US5840313A
(en)
|
1990-09-27 |
1998-11-24 |
Syntello Vaccine Development Kb |
Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
|
|
AU1753892A
(en)
|
1991-04-10 |
1992-11-17 |
General Hospital Corporation, The |
Mammalian gap-43 compositions and methods of use
|
|
US5350835A
(en)
|
1991-11-05 |
1994-09-27 |
Board Of Regents, University Of Texas |
Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
|
|
US5994108A
(en)
|
1991-11-05 |
1999-11-30 |
Board Of Regents, The University Of Texas System |
Mutant TAR virus and transdominant tat mutants as pharmacological agents
|
|
CA2131620A1
(en)
|
1992-03-20 |
1993-09-30 |
Louis C. Smith |
A dna transporter system and method of use
|
|
WO1993019768A1
(en)
|
1992-04-03 |
1993-10-14 |
The Regents Of The University Of California |
Self-assembling polynucleotide delivery system
|
|
WO1994004562A1
(en)
|
1992-08-13 |
1994-03-03 |
The General Hospital Corporation |
Mammalian gap-43 compositions and methods of use
|
|
ES2123062T3
(es)
*
|
1992-08-21 |
1999-01-01 |
Biogen Inc |
Polipeptidos de transporte derivados de la proteina tat.
|
|
HUT71860A
(en)
|
1992-08-27 |
1996-02-28 |
Deakin Res Ltd |
Retro-, inverso-, and retro-inverso synthetic peptide analogues
|
|
US5545551A
(en)
|
1992-08-28 |
1996-08-13 |
Mt. Sinai School Of Medicine Of The City University Of New York |
Cloning and expression of pur protein
|
|
AU6568594A
(en)
|
1993-04-14 |
1994-11-08 |
Boehringer Mannheim Gmbh |
Nucleic acid tranfer peptides and their use for injecting nucleic acids into eucaryotic cells
|
|
EP0679716A4
(en)
|
1993-11-12 |
1999-06-09 |
Kenichi Matsubara |
GENE SIGNATURE.
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US5807746A
(en)
|
1994-06-13 |
1998-09-15 |
Vanderbilt University |
Method for importing biologically active molecules into cells
|
|
WO1996034093A1
(en)
|
1995-04-25 |
1996-10-31 |
Baxter International Inc. |
Composition containing collagenase and chymopapain for isolating hepatocytes and pancreatic islet cells
|
|
ATE365808T1
(de)
|
1995-07-28 |
2007-07-15 |
Marie Curie Cancer Care |
Transportproteine und deren verwendungen
|
|
WO1997010836A1
(en)
|
1995-09-21 |
1997-03-27 |
Innapharma, Inc. |
Peptides and peptidomimetics inhibiting the oncogenic action of p21 ras
|
|
IE80466B1
(en)
|
1995-11-10 |
1998-07-29 |
Elan Corp Plc |
Peptides which enhance transport across tissues and methods of identifying and using the same
|
|
US6630351B1
(en)
|
1999-06-07 |
2003-10-07 |
Mirus Corporation |
Compositions and methods for drug delivery using pH sensitive molecules
|
|
US5877282A
(en)
|
1996-09-20 |
1999-03-02 |
Bristol-Myers Squibb Company |
Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
|
|
US6187817B1
(en)
|
1996-10-03 |
2001-02-13 |
Southern Illinois University School Of Medicine |
Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds
|
|
US6361938B1
(en)
|
1996-11-08 |
2002-03-26 |
Elan Corporation, Plc |
Peptides which enhance transport across tissues and methods of identifying and using the same
|
|
WO1998023781A1
(en)
|
1996-11-26 |
1998-06-04 |
Johns Hopkins University |
Ligand detection system and methods of use thereof
|
|
US5989814A
(en)
|
1997-04-01 |
1999-11-23 |
Reagents Of The University Of California |
Screening methods in eucaryotic cells
|
|
US5880261A
(en)
|
1997-04-03 |
1999-03-09 |
Waeber; Gerard |
Transcription factor Islet-Brain 1 (IB1)
|
|
WO1998047913A2
(en)
|
1997-04-18 |
1998-10-29 |
The University Of Medicine And Dentistry Of New Jersey |
Inhibition of hiv-1 replication by a tat rna-binding domain peptide analog
|
|
US6043083A
(en)
*
|
1997-04-28 |
2000-03-28 |
Davis; Roger J. |
Inhibitors of the JNK signal transduction pathway and methods of use
|
|
JP4129298B2
(ja)
|
1997-05-15 |
2008-08-06 |
サイトジェン コーポレーション |
胃腸管（ｇｉｔ）輸送受容体に結合するランダムペプチド、及び関連した方法
|
|
CN1263473A
(zh)
|
1997-05-21 |
2000-08-16 |
利兰·斯坦福青年大学托管委员会 |
增加跨生物膜转运的组合物和方法
|
|
FR2767323B1
(fr)
|
1997-08-12 |
2001-01-05 |
Synt Em |
Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives
|
|
EP0897002A3
(en)
|
1997-08-14 |
2001-10-04 |
Smithkline Beecham Plc |
U62317, a protein having a JNK-binding domain
|
|
WO1999016787A1
(en)
|
1997-09-26 |
1999-04-08 |
Washington University |
Cell death agonists
|
|
US6420031B1
(en)
|
1997-11-03 |
2002-07-16 |
The Trustees Of Princeton University |
Highly transparent non-metallic cathodes
|
|
BR9812944A
(pt)
*
|
1997-10-20 |
2000-08-08 |
Hoffmann La Roche |
Inibidores bicìclicos da cinase
|
|
US6270956B1
(en)
|
1997-12-11 |
2001-08-07 |
The Salk Institute For Biological Studies |
Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor
|
|
EP0947524A1
(en)
|
1998-03-30 |
1999-10-06 |
Upither B.V. |
Novel peptides for the treatment of autoimmune diseases
|
|
US6248558B1
(en)
|
1998-03-31 |
2001-06-19 |
Vanderbilt University |
Sequence and method for genetic engineering of proteins with cell membrane translocating activity
|
|
JP2002513008A
(ja)
|
1998-04-29 |
2002-05-08 |
ジョージタウン ユニヴァーシティー |
Ｈｌａ−作動薬及び拮抗薬としてのｈｌａ結合性化合物の同定及び使用方法
|
|
WO1999058692A2
(en)
|
1998-05-13 |
1999-11-18 |
Incyte Pharmaceuticals, Inc. |
Human apoptosis associated proteins
|
|
US6811992B1
(en)
|
1998-05-14 |
2004-11-02 |
Ya Fang Liu |
Method for identifying MLK inhibitors for the treatment of neurological conditions
|
|
AU3714499A
(en)
|
1998-05-14 |
1999-11-29 |
Pasteur Merieux Serums Et Vaccins |
Hepatitis c virus mimotopes
|
|
CA2331384A1
(en)
|
1998-06-18 |
1999-12-23 |
Dnavec Research Inc. |
Nucleic acid transfer phage
|
|
US6589503B1
(en)
|
1998-06-20 |
2003-07-08 |
Washington University |
Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
|
|
US8038984B2
(en)
|
1998-06-20 |
2011-10-18 |
Washington University |
Membrane-permeant peptide complexes for treatment of sepsis
|
|
CA2328457A1
(en)
|
1998-06-20 |
1999-12-29 |
Washington University |
Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
|
|
EP1107998B1
(en)
|
1998-08-28 |
2004-02-04 |
Gryphon Sciences |
Method for the preparation of polyamide chains of precise length, their conjugates with proteins
|
|
EP1126855B1
(en)
|
1998-09-25 |
2007-05-09 |
Cephalon, Inc. |
Use of fused pyrrolocarbazoles for preventing/treating damage to sensory hair cells and cochlear neurons
|
|
US20020090696A1
(en)
|
1998-12-08 |
2002-07-11 |
Miller Carol A. |
Treating neurological disorders using human apoptosis inhibiting protein
|
|
US6656474B1
(en)
|
1999-01-15 |
2003-12-02 |
Regeneron Pharmaceuticals, Inc. |
Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
|
|
US6673908B1
(en)
|
1999-02-22 |
2004-01-06 |
Nuvelo, Inc. |
Tumor necrosis factor receptor 2
|
|
JP2003506071A
(ja)
|
1999-05-28 |
2003-02-18 |
アポプトシス テクノロジー，アイエヌシー． |
アポトーシスを制御する化合物および方法ならびにアポトーシスを制御する化合物を製造およびスクリーニングする方法
|
|
US7510824B2
(en)
|
1999-06-02 |
2009-03-31 |
Nono Inc. |
Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
|
|
AU5316900A
(en)
|
1999-06-03 |
2000-12-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk)
|
|
US6593292B1
(en)
|
1999-08-24 |
2003-07-15 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
US20030104622A1
(en)
|
1999-09-01 |
2003-06-05 |
Robbins Paul D. |
Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
|
|
AU7473500A
(en)
|
1999-09-01 |
2001-03-26 |
University Of Pittsburgh |
Identification of peptides that facilitate uptake and cytoplasmic and/or nucleartransport of proteins, dna and viruses
|
|
US20040082509A1
(en)
|
1999-10-12 |
2004-04-29 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US20030108539A1
(en)
|
2000-02-14 |
2003-06-12 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US6610820B1
(en)
|
1999-10-12 |
2003-08-26 |
University Of Lausanne |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US8183339B1
(en)
|
1999-10-12 |
2012-05-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
CA2392615A1
(en)
|
1999-12-06 |
2001-06-07 |
The General Hospital Corporation |
Pancreatic stem cells and their use in transplantation
|
|
NZ519447A
(en)
|
1999-12-16 |
2004-03-26 |
Biogen Inc |
Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
|
|
AU7294401A
(en)
|
2000-06-16 |
2002-01-02 |
Zealand Pharmaceuticals As |
Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
|
|
US6586403B1
(en)
|
2000-07-20 |
2003-07-01 |
Salpep Biotechnology, Inc. |
Treating allergic reactions and inflammatory responses with tri-and dipeptides
|
|
US6897231B2
(en)
|
2000-07-31 |
2005-05-24 |
Signal Pharmaceuticals, Inc. |
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
|
|
US7034109B2
(en)
|
2000-10-13 |
2006-04-25 |
Christophe Bonny |
Intracellular delivery of biological effectors
|
|
US7033597B2
(en)
|
2000-10-13 |
2006-04-25 |
Université de Lausanne |
Intracellular delivery of biological effectors
|
|
EP1333846B1
(en)
|
2000-10-17 |
2012-04-18 |
Diabcell Pty Limited |
Preparation and xenotransplantation or porcine islets
|
|
US20030077826A1
(en)
|
2001-02-02 |
2003-04-24 |
Lena Edelman |
Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
|
|
US7199124B2
(en)
|
2001-02-02 |
2007-04-03 |
Takeda Pharmaceutical Company Limited |
JNK inhibitor
|
|
US20030091640A1
(en)
|
2001-02-08 |
2003-05-15 |
Srinivasan Ramanathan |
Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents
|
|
DE60233137D1
(de)
|
2001-02-16 |
2009-09-10 |
Univ R |
Transporter mit beabstandeten arginin-teilchen
|
|
DE10117281A1
(de)
|
2001-04-06 |
2002-10-24 |
Inst Molekulare Biotechnologie |
Peptid zur Diagnose und Therapie der Alzheimer-Demenz
|
|
EP1373308B1
(en)
|
2001-04-06 |
2006-10-25 |
Thomas Jefferson University |
Antagonist for multimerization of hiv-1 vif protein
|
|
AU2002322519A1
(en)
|
2001-07-17 |
2003-03-03 |
Incyte Genomics, Inc. |
Proteins associated with cell growth, differentiation, and death
|
|
BR0212760A
(pt)
|
2001-09-19 |
2004-12-07 |
Aventis Pharma Sa |
Compostos quìmicos
|
|
WO2003057725A2
(en)
|
2002-01-09 |
2003-07-17 |
University Of Lausanne |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
|
WO2003075917A1
(en)
|
2002-03-08 |
2003-09-18 |
Signal Pharmaceuticals, Inc. |
Combination therapy for treating, preventing or managing proliferative disorders and cancers
|
|
US20040034084A1
(en)
*
|
2002-05-24 |
2004-02-19 |
Celgene Corporation |
Methods for using JNK inhibitors for treating or preventing disease-related wasting
|
|
CN1668733A
(zh)
*
|
2002-05-30 |
2005-09-14 |
细胞基因公司 |
利用jnk或mkk抑制剂调节细胞分化并治疗骨髓增生异常和脊髓发育不良综合症的方法
|
|
SE0201863D0
(en)
|
2002-06-18 |
2002-06-18 |
Cepep Ab |
Cell penetrating peptides
|
|
JP2004066595A
(ja)
|
2002-08-05 |
2004-03-04 |
Canon Finetech Inc |
記録装置およびレジストレーション用パターンの記録方法
|
|
EP1542768A1
(en)
|
2002-09-20 |
2005-06-22 |
Alcon, Inc. |
Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
|
|
DE50209178D1
(de)
|
2002-10-11 |
2007-02-15 |
Imvision Gmbh |
Moduläre Antigen-Transporter Moleküle (MAT-Moleküle) zur Modulierung von Immunreaktionen, zugehörige Konstrukte, Verfahren und Verwendungen
|
|
ZA200503242B
(en)
*
|
2002-10-24 |
2006-10-25 |
Celgene Corp |
Treatment of pain with JNK inhibitors
|
|
US20040186052A1
(en)
|
2002-10-24 |
2004-09-23 |
Suhasini Iyer |
Cytomodulating peptides and methods for treating neurological disorders
|
|
US20050019366A1
(en)
|
2002-12-31 |
2005-01-27 |
Zeldis Jerome B. |
Drug-coated stents and methods of use therefor
|
|
US7166692B2
(en)
|
2003-03-04 |
2007-01-23 |
Canbrex Bio Science Walkersville, Inc. |
Intracellular delivery of small molecules, proteins, and nucleic acids
|
|
EP2295433A3
(en)
|
2003-03-06 |
2011-07-06 |
Eisai R&D Management Co., Ltd. |
JNK inhibitors
|
|
US7468418B2
(en)
|
2003-04-29 |
2008-12-23 |
Avi Biopharma., Inc. |
Compositions for enhancing transport of molecules into cells
|
|
US20050048995A1
(en)
|
2003-08-25 |
2005-03-03 |
Motorola, Inc. |
System and method for controlling the operating characteristics of a buffer
|
|
KR100685345B1
(ko)
|
2004-03-27 |
2007-02-22 |
학교법인조선대학교 |
세포사 유도 펩타이드
|
|
JP5080241B2
(ja)
|
2004-04-08 |
2012-11-21 |
メルク セローノ ソシエテ アノニム |
Ｊｎｋ阻害剤およびスクロスポリンを含んでなる組成物
|
|
JP2008510766A
(ja)
|
2004-08-27 |
2008-04-10 |
ゲーペーツェー ビオテック アーゲー |
ピリミジン誘導体
|
|
US20060094753A1
(en)
|
2004-10-29 |
2006-05-04 |
Alcon, Inc. |
Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
|
|
US7803824B2
(en)
*
|
2004-10-29 |
2010-09-28 |
Alcon, Inc. |
Use of inhibitors of Jun N-terminal kinases to treat glaucoma
|
|
EP1656951A1
(en)
|
2004-11-12 |
2006-05-17 |
Xigen S.A. |
Conjugates with enhanced cell uptake activity
|
|
US20100256041A1
(en)
|
2004-11-12 |
2010-10-07 |
Christophe Bonny |
Conjugate Molecule Compounds With Enhanced Cell Uptake Activity
|
|
EP1661912A1
(en)
|
2004-11-29 |
2006-05-31 |
Xigen S.A. |
Fusion protein comprising a BH3-domain of a BH3-only protein
|
|
EP1676574A3
(en)
*
|
2004-12-30 |
2006-07-26 |
Johnson & Johnson Vision Care, Inc. |
Methods for promoting survival of transplanted tissues and cells
|
|
ZA200706662B
(en)
*
|
2005-01-13 |
2009-04-29 |
Signal Pharmaceiticals Llc |
Haloaryl substituted Aminopurines, compositions thereof, and methods of treatment therewith
|
|
US20060223807A1
(en)
|
2005-03-29 |
2006-10-05 |
University Of Massachusetts Medical School, A Massachusetts Corporation |
Therapeutic methods for type I diabetes
|
|
CA2606110A1
(en)
|
2005-04-29 |
2006-12-07 |
Celgene Corporation |
Solid forms of 1-(5-(1h-1,2,4-triazol-5-yl)(1h-indazol-3-yl))-3-(2-piperidylethoxy)benzene
|
|
US20070015779A1
(en)
|
2005-04-29 |
2007-01-18 |
John Griffin |
Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
|
|
US20070003531A1
(en)
|
2005-06-30 |
2007-01-04 |
University Of Connecticut |
Methods for improving immunotherapy by enhancing survival of antigen-specific cytotoxic T lymphocytes
|
|
US8080517B2
(en)
|
2005-09-12 |
2011-12-20 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
WO2007031098A1
(en)
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
|
US10045953B2
(en)
|
2006-07-06 |
2018-08-14 |
Case Western Reserve University |
Ceramide composition and method of use
|
|
EP1884521A1
(en)
|
2006-07-31 |
2008-02-06 |
Xigen S.A. |
Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins
|
|
US20080051410A1
(en)
*
|
2006-08-02 |
2008-02-28 |
Northwestern University |
Protein Kinase Targeted Therapeutics
|
|
WO2008028860A1
(en)
|
2006-09-08 |
2008-03-13 |
F. Hoffmann-La Roche Ag |
Benzotriazole kinase modulators
|
|
CA2663545A1
(en)
*
|
2006-09-19 |
2008-03-27 |
Phylogica Limited |
Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof
|
|
GB0702259D0
(en)
*
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-azaindole derivatives
|
|
DK2282779T3
(da)
|
2008-04-29 |
2013-05-27 |
Pharnext |
Nye terapeutiske fremgangsmåder til behandling af alzheimer sygdom og beslægtede lidelser gennem en modulation af cellestress-respons
|
|
HUE024146T2
(en)
|
2008-05-07 |
2016-02-29 |
Univ California |
Medical filling and enrichment of eye surface lubrication
|
|
WO2009143864A1
(en)
*
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
|
|
WO2009143865A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
US20100183633A1
(en)
|
2008-12-04 |
2010-07-22 |
University Of Massachusetts |
Interleukin 6 and tumor necrosis factor alpha as biomarkers of jnk inhibition
|
|
WO2010072228A1
(en)
|
2008-12-22 |
2010-07-01 |
Xigen S.A. |
Novel transporter constructs and transporter cargo conjugate molecules
|
|
WO2010073104A2
(en)
|
2008-12-23 |
2010-07-01 |
Carmel - Haifa University Economic Corp Ltd. |
Improving cognitive function
|
|
US8450363B2
(en)
|
2009-02-06 |
2013-05-28 |
Elan Pharmaceuticals, Inc. |
Inhibitors of Jun N-terminal kinase
|
|
WO2010113753A1
(ja)
|
2009-03-30 |
2010-10-07 |
参天製薬株式会社 |
ＪＮＫ（ｃ－Ｊｕｎアミノ末端キナーゼ）阻害ペプチドを用いた網膜疾患の予防または治療剤、網膜疾患の予防または治療方法、ならびに、その使用
|
|
KR101506318B1
(ko)
*
|
2009-08-10 |
2015-03-26 |
에프. 호프만-라 로슈 아게 |
Ｊｎｋ 억제제
|
|
EP3011970A3
(en)
|
2009-10-22 |
2016-06-08 |
F. Hoffmann-La Roche AG |
Modulation of axon degeneration
|
|
EP3266462A1
(en)
|
2009-12-31 |
2018-01-10 |
Stealth Peptides International, Inc. |
Methods for performing a coronary artery bypass graft procedure
|
|
CN102918046A
(zh)
*
|
2010-06-04 |
2013-02-06 |
霍夫曼-拉罗奇有限公司 |
Jnk的抑制剂
|
|
WO2011160653A1
(en)
|
2010-06-21 |
2011-12-29 |
Xigen S.A. |
Novel jnk inhibitor molecules
|
|
WO2012048893A1
(en)
|
2010-10-14 |
2012-04-19 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
|
|
WO2012048721A1
(en)
|
2010-10-14 |
2012-04-19 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
|
|
US8471027B2
(en)
|
2011-04-06 |
2013-06-25 |
Hoffmann-La Roche Inc. |
Adamantyl compounds
|
|
JP2015500213A
(ja)
|
2011-11-30 |
2015-01-05 |
ザイジェン インフラメーション リミテッド |
眼乾燥症候群を処置するためのｊｎｋシグナル伝達経路の細胞透過性ペプチド阻害剤の使用
|
|
WO2013091670A1
(en)
|
2011-12-21 |
2013-06-27 |
Xigen S.A. |
Novel jnk inhibitor molecules for treatment of various diseases
|
|
KR20160023669A
(ko)
|
2013-06-26 |
2016-03-03 |
자이겐 인플라메이션 리미티드 |
다양한 질병의 치료를 위한 jnk 신호 전달 경로의 세포 투과성 펩타이드 억제자의 새로운 용도
|
|
WO2014206427A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
WO2014206426A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
|
JP2015197193A
(ja)
|
2014-04-02 |
2015-11-09 |
トヨタ自動車株式会社 |
車両用無段変速機の油圧制御装置
|
|
EP3160989A2
(en)
|
2014-06-26 |
2017-05-03 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
|
CN107969126A
(zh)
|
2015-06-26 |
2018-04-27 |
埃克西金炎症有限公司 |
Jnk信号转导通路的细胞穿透肽抑制剂用于治疗轻度认知损害的新用途
|